<DOC>
	<DOCNO>NCT01128751</DOCNO>
	<brief_summary>In randomize controlled trial patient undergoing aortic valve replacement recruit 3 group . Patients receive either intra-aortic filter ( Embol-X ) , design reduce solid microemboli mechanical surgical intervention , dynamic bubble-trap ( DBT ) , design reduce gaseous microemboli cardiopulmonary bypass ( CPB ) , additional device ( control-group ) . Cognitive functioning assess 3 week 1 day 3 month ( +/- 1 week ) valve replacement . Furthermore , cerebral magnetic resonance imaging ( MRI ) carry 2-6 day surgery . Primary endpoint cognitive outcome filter group compare control . Secondary endpoint number acute ischemic lesion CABG .</brief_summary>
	<brief_title>Elimination Microemboli During Aortic Valve Replacement</brief_title>
	<detailed_description />
	<criteria>Age &gt; 18 Elective aortic valve replacement Informed consent German language Neurological psychiatric disease would conflict neuropsychological testing ( e.g . stroke , TBI , schizophrenia , etc . ) ; major surgery CPB plan within 3 month valve replacement Contraindication MRI assessment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>Cognition</keyword>
	<keyword>Neuroprotection</keyword>
	<keyword>Cardiopulmonary bypass</keyword>
	<keyword>Aortic valve replacement</keyword>
	<keyword>Micro-emboli</keyword>
</DOC>